Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- Global Autoimmune Disorder Drug Delivery Devices Market 2021-2026 - Home Care Settings Will Dominate due to Longer Wait Times in Hospitals - ResearchAon October 15, 2021 at 4:19 am
The "Global Autoimmune Disorder Drug Delivery Devices Market Research Report: Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering. According to the report, the market is ...
- For Rachel Farnsworth, Healing Her Daughter's Autoimmune Disease Is Just the Tip of the Icebergon October 14, 2021 at 4:21 pm
Rachel Claire Farnsworth has always felt called upon to help and heal other people. But, having spent so many years locked in abusive relationships, was never able to reach ...
- COVID-19 Testing Is More Common in Autoimmune and Inflammatory Disease Patients, but Infection Risk Is Noton October 14, 2021 at 6:03 am
Learn more about research on COVID-19 testing and infection rates in people with autoimmune and inflammatory diseases.
- Autoimmune Diseases Drugs Market Size,Growth 2021 – Global Trends, Market Demand, Industry Analysis, Opportunities and Forecast 2025on October 14, 2021 at 12:13 am
Global Autoimmune Diseases Drugs Market Report provides strategic insights into market opportunities, trends, and competitive landscapes in the industry. Autoimmune Diseases Drugs Market report ...
- 2/3rds of celiac disease patients are womenon October 13, 2021 at 7:25 am
Like other autoimmune diseases, celiac disease affects more women than men. Two-thirds of those currently diagnosed are female. For them, a gluten free diet isn’t ...
- Demand for Autoimmune Disease Diagnostic Products Remains High in North Americaon October 12, 2021 at 11:47 pm
Around 3 of the people in the U S are affected by autoimmune diseases every year according to Johns Hopkins University In such diseases the immune system malfunctions and starts attacking the healthy ...
- Autoimmune Disease Drug Market 2021 : Industry Size, Growth Opportunities and Restraint to 2026 with Leading Regions and Countries Dataon October 11, 2021 at 9:26 pm
Global “Autoimmune Disease Drug Market" is expected to grow at a steady growth during the forecast period 2021-2026, Autoimmune Disease Drug Market report offers insights into the latest trends. It ...
- ChemoCentryx soars 89% after FDA approves first drug in a decade to treat autoimmune disease vasculitison October 8, 2021 at 9:27 am
The jump in ChemoCentryx stock cuts down on the loss registered on a year-to-date basis but it's still about 50% below highs from February.
- ChemoCentryx's drug gets U.S. FDA nod for treating rare autoimmune diseaseon October 8, 2021 at 5:21 am
The U.S. Food and Drug Administration on Friday approved ChemoCentryx Inc's lead drug candidate, Avacopan, for treating a rare, fatal autoimmune disease, the biopharmaceutical company said.
- SDOHs Tied To Poor Autoimmune Disease Outcomes Among Minoritieson October 5, 2021 at 10:00 am
Research shows that minority populations with autoimmune diseases are more likely to experience poor outcomes due to social determinants of health.
via Bing News